This report presents the findings of a workshop in which key figures from the UK Department of Health, academic experts, and lawyers discussed the patenting of human DNA sequencing, to find the best balance between developing incentives for commercial research and development, whilst safeguarding tangible benefits to public health services.
This report presents the views of a number of leading medical and legal experts on the complex evidential issues arising at inquests into sudden adult deaths. Participants include Michael Burgess OBE (HM Coroner of the Royal Household and Legal Secretary of the Coroners’ Society of England & Wales) and Professor Hugh Watkins (an expert in molecular genetics and molecular biology of heart muscle disease).
What do we want from medical technology, and how can we get it?
The complexity of the regulatory framework and the impact of a small number of high-profile failures, notably the PIP breast implant scandal, have led to widespread misunderstanding among heath-care professionals and patients alike regarding the regulation of medical devices. This policy brief addresses a series of interrelated questions on how regulatory reform in the European Medical Devices sector should proceed.
This report examines the significant changes to the European legal system in recent years – including the increasing role of alternative dispute resolution (ADR), Consumer ADR (CDR), ombudsmen, and regulatory redress as alternatives to litigation and collective actions – and assesses to what degree these approaches could be adopted in China.
Chief Ombudsman of the Ombudsman Service Lewis Shand Smith assesses the major shifts being felt across the civil justice landscape in the UK, in this policy brief published in association with Ombudsman Services.
The policy brief explores the implications of the recent European Commission Directive 2013/11/EU, due for implementation before the next UK general election in 2015, which requires Alternative Dispute Resolution (ADR) entities to be available for all business-to-consumer disputes.